ETC-206 is a selective MNK1/2 inhibitor with IC50 = 64 nM (for MNK1) and IC50 = 84 nM (for MNK2). ETC-206 in combination with dasatinib prevents BC-CML LSC self-renewal in vitro and enhances dasatinib antitumor activity in vivo.
Chemical Name:
4-(6-(4-(morpholine-4-carbonyl)phenyl)imidazo[1,2-a]pyridin-3-yl)benzonitrile
MNK inhibitor Related Products:
Tomivosertib